| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Cummings Keith Lamont is a Chief Financial Officer at PLIANT THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $345K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | PLRX Pliant Therapeutics, Inc. | Chief Financial Officer | Sell | 24,002 | $1.28 | $30,722.56 | -7.5% | - | - | |
| Jan 17, 2025 | PLRX Pliant Therapeutics, Inc. | Chief Financial Officer | Sell | 20,148 | $11.20 | $225,679.76 | -7.1% | -87.0% | -88.5% | |
| Jul 10, 2024 | PLRX Pliant Therapeutics, Inc. | Chief Financial Officer | Sell | 10,911 | $11.56 | $126,131.16 | -3.7% | +1.4% | -87.4% | |
| Jan 17, 2024 | PLRX Pliant Therapeutics, Inc. | Chief Financial Officer | Sell | 9,781 | $17.23 | $168,526.63 | -4.8% | -25.7% | -35.0% | |
| Jul 17, 2023 | PLRX Pliant Therapeutics, Inc. | Chief Financial Officer | Sell | 19,771 | $18.01 | $356,057.92 | -8.8% | -13.7% | -24.3% | |
| Mar 30, 2023 | PLRX Pliant Therapeutics, Inc. | Chief Financial Officer | Sell | 9,960 | $26.52 | $264,148.16 | -6.3% | -28.3% | -43.9% | |
| Jan 23, 2023 | PLRX Pliant Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 30,000 | $35.00 | $1,050,000.00 | -26.2% | +0.9% | -42.4% | |
| Dec 20, 2022 | PLRX Pliant Therapeutics, Inc. | Chief Financial Officer | Sell | 9,643 | $19.10 | $184,204.44 | -10.7% | +45.1% | -14.4% | |
| Dec 1, 2020 | PLRX Pliant Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 18,734 | $30.00 | $562,035.05 | -15.4% | - | - |